DIVIDEND ANNOUNCEMENT: Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on 07/30/2026 declared a dividend of $0.9400 per share

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) on 07/30/2026 declared a dividend of $ 0.9400 per share payable on August 31, 2026 to shareholders of record as of August 18, 2026.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has paid dividends since 1970, has a current dividend yield of 0.5406804681% and has increased its dividends for 0 successive years.

Regeneron Pharmaceuticals, Inc.'s market cap is $ 71,643,559,240 and has a PE ratio of 16.94. The stock price closed yesterday at $ 695.42 and has a 52 week low/high of $ 541.00 and $ 821.11.

Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. Co. invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases.

For more information on Regeneron Pharmaceuticals, Inc. click here.